The researchers behind this study hope their work will eventually lead to routine pharmacogenetic screening before prescribing GLP-1 receptor agonists, so that patients who are unlikely to respond well can be directed toward alternative treatments sooner
For the OSA indication after SURMOUNT-OSA, UHCs PA requires confirmed AHI of 15 or higher on polysomnography and BMI of 30 or higher
The rising incidences of diabetes and obesity as well as other associated diseases such as cardiovascular diseases due to unhealthy and sedentary lifestyles, rapid urbanization, aging population and hereditary factors are driving the demand for advanced treatment and management solutions which are readily available at hospitals
This approach increases the risk of adverse effects without evidence of improved weight loss outcomes
If independently replicated, this finding would represent a fundamental revision of psychedelic pharmacology
Its a tasty, not-so-decadent way to boost protein